BCR-ABL transcript variant's significance in chronic myeloid leukemia in chronic phase: Institutional experience from a developing country

被引：0
|
作者：
Prasad, S. K. [1 ]
Chennamaneni, R. [1 ]
Stalin, B. [1 ]
Konatam, M. L. [1 ]
Gundeti, S. [1 ]
机构：
[1] Nizams Inst Med Sci, Med Oncol, Hyderabad, India
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1099P
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of BCR-ABL rearrangement in chronic myeloid leukemia
    Colleoni, GWB
    Costa, FF
    Grignolli, CRE
    Silva, RS
    Chauffaille, MLLF
    Kerbauy, J
    Saad, STO
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1996, 29 (10) : 1307 - 1310
  • [2] Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase
    Michael Lauseker
    Benjamin Hanfstein
    Claudia Haferlach
    Susanne Schnittger
    Markus Pfirrmann
    Alice Fabarius
    Brigitte Schlegelberger
    Susanne Saußele
    Christian T. Dietz
    Philipp Erben
    Rüdiger Hehlmann
    Joerg Hasford
    Andreas Hochhaus
    Martin C. Müller
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1965 - 1969
  • [3] BCR-ABL Mutations in Chronic Myeloid Leukemia
    Ernst, Thomas
    La Rosee, Paul
    Mueller, Martin C.
    Hochhaus, Andreas
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (05) : 997 - +
  • [4] Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase
    Lauseker, Michael
    Hanfstein, Benjamin
    Haferlach, Claudia
    Schnittger, Susanne
    Pfirrmann, Markus
    Fabarius, Alice
    Schlegelberger, Brigitte
    Saussele, Susanne
    Dietz, Christian T.
    Erben, Philipp
    Hehlmann, Rudiger
    Hasford, Joerg
    Hochhaus, Andreas
    Mueller, Martin C.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (11) : 1965 - 1969
  • [5] BCR-ABL IN CHRONIC MYELOID-LEUKEMIA
    不详
    LANCET, 1986, 2 (8501): : 258 - 259
  • [6] Response to Imatinib Treatment in Chronic Myeloid Leukemia According to BCR-ABL Transcript
    Acosta Hernandez, Titania del Carmen
    Best Aguilera, Carlos Roberto
    Villela Martinez, Luis Mario
    Guzman Hernandez, Alicia Elizabeth
    Robles Rodriguez, Arianna
    Lopez Hernandez, Juan Carlos
    Gomez Vazquez, Oscar Rodrigo
    Rivera Mendoza, Laura Adriana
    Garcia Reyes, Barbara
    Gutierrez Alatorre, Aldo Fernando Adrian
    Calderon Valdez, Areli Sarai
    Visuetti Pimentel, Saribethe Mahely
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S242 - S243
  • [7] Chronic Myeloid Leukemia: Clinical Prestantation According to Bcr-Abl Transcript Variants
    Acosta Hernandez, Titania del Carmen
    Best Aguilera, Carlos Roberto
    Villela Martinez, Luis Mario
    Guzman Hernandez, Alicia Elizabeth
    Robles Rodriguez, Arianna
    Lopez Hernandez, Juan Carlos
    Gomez Vazquez, Oscar Rodrigo
    Rivera Mendoza, Laura Adriana
    Garcia Reyes, Barbara
    Gutierrez Alatorre, Aldo Fernando Adrian
    Calderon Valdez, Areli Sarai
    Visuetti Pimentel, Saribethe Mahely
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S243 - S243
  • [8] Prognostic significance of the type of BCR-ABL transcript in chronic myelogenous leukemia (CML)
    Mantzourani, M
    Viniou, N
    Stavroyianni, N
    Rombos, J
    Meletis, J
    Loukopoulos, D
    Yataganas, X
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 275 - 275
  • [9] Primary imatinib resistance in chronic myeloid leukemia patients in a developing country: BCR-ABL kinase domain mutations or BCR-ABL independent mechanisms?
    Yap, E.
    Tumian, N. R.
    Azma, R. Z.
    Sharifah, N. A.
    Salwati, S.
    Hamidah, N. H.
    Elias, M. H.
    Wong, C. L.
    MALAYSIAN JOURNAL OF PATHOLOGY, 2017, 39 (02) : 107 - 113
  • [10] Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients
    Martinelli, G
    Iacobucci, I
    Rosti, G
    Pane, F
    Amabile, M
    Castagnetti, F
    Cilloni, D
    Soverini, S
    Testoni, N
    Specchia, G
    Merante, S
    Zaccaria, A
    Frassoni, F
    Saglio, G
    Baccarani, M
    ANNALS OF ONCOLOGY, 2006, 17 (03) : 495 - 502
12345